Plasma Nitric Oxide Products Correlate with Cardiac Index of Congenital Heart Disease

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Pediatric Cardiology

• Publication date

  2000-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s002460010086PMID 10865019
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of vesnarinone on nitric oxide synthesis in rat cardiac myocytes.

  1998influential reference
• Relation between plasma nitrate and mean pulmonary arterial pressure in ventricular septal defect

  1998cited by this paper
• TNF-α causes reversible in vivo systemic vascular barrier dysfunction via NO-dependent and -independent mechanisms.

  1997cited by this paper
• Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: role of endothelin, nitric oxide, and angiotensin II

  1997cited by this paper
• Clinical validation of cardiac output measurements using femoral artery thermodilution with direct Fick in ventilated children and infants

  1997cited by this paper
• Nitric oxide and cardiac function.

  1996cited by this paper
• Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes.

  1995cited by this paper
• Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs.

  1995cited by this paper
• Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure.

  1994cited by this paper
• Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

  1994cited by this paper
• The L-arginine-nitric oxide pathway.

  1993cited by this paper
• Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

  1993cited by this paper
• Negative inotropic effects of cytokines on the heart mediated by nitric oxide.

  1992cited by this paper
• The 1991 Ulf von Euler Lecture. The L-arginine: nitric oxide pathway.

  1992cited by this paper
• Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

  1991cited by this paper
• Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

  1990cited by this paper
• Mechanisms of pulmonary edema induced by tumor necrosis factor-alpha.

  1990cited by this paper
• Relationship between plasma atrial natriuretic polypeptide concentration and hemodynamic measurements in children with congenital heart diseases.

  1987cited by this paper
• Analysis of factors affecting the variability of Fick versus indicator dilution measurements of cardiac output.

  1985cited by this paper
• Blood nitrates and infantile methemoglobinemia.

  1982cited by this paper
• The estimation of oxygen consumption.

  1970cited by this paper

• Congenital Heart Disease: An Immunological Perspective

  2021cites this paper
• Immunity and inflammation: the neglected key players in congenital heart disease?

  2021cites this paper
• Evaluation of add on effect of carvedilol on standard protocol of digoxin, frusemide and benazepril in the management of dilated cardiomyopathy in dogs

  2018cites this paper
• The History and Future of Beta Blockers in Heart Failure Treatment in Children and Adults

  2017cites this paper
• Serum C-reactive protein levels and body mass index in children and adolescents with CHD

  2016cites this paper
• Changes in serum level of ghrelin, tumor necrosis factor-alpha and interleukin-6 in children with congenital heart disease

  2015cites this paper
• Comparative assessment of N-terminal pro-B-type natriuretic peptide, nitric oxide and echocardiography for diagnosis of dilated cardiomyopathy in dogs

  2014cites this paper
• Inflammatory Cytokines, Apoptotic, Tissue Injury and Remodeling Biomarkers in Children with Congenital Heart Disease

  2014cites this paper
• Neurohormonal and cytokine fluctuations following transcatheter closure for an atrial septal defect.

  2012cites this paper
• Die Pathogenese der chronischen Herzinsuffizienz bei Säuglingen mit angeborenem Herzfehler und Links-Rechts-Shunt am Beispiel der klinischen Symptome Tachypnoe und Gedeihstörung

  2012cites this paper
• The usefulness of brain natriuretic peptide in complex congenital heart disease: a systematic review.

  2012cites this paper
• The usefulness of brain natriuretic peptide in simple congenital heart disease – a systematic review

  2012cites this paper
• Plasma endothelin-1 and nitrate levels in Down’s syndrome with complete atrioventricular septal defect-associated pulmonary hypertension: a comparison with non-Down’s syndrome children

  2009cites this paper
• Plasma levels of nitric oxide in children with congenital heart disease and increased pulmonary blood flow.

  2007cites this paper
• Coronary slow flow phenomenon: an angiographic curiosity.

  2004cites this paper
• Secretion of A-type and B-type natriuretic peptides into the bloodstream and pericardial space in children with congenital heart disease.

  2003cites this paper
• Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease.

  2003cites this paper
• Plasma Levels of Nitrate in Congenital Heart Disease: Comparison with Healthy Children

  2002cites this paper
• Endogenous nitric oxide and soluble tumor necrosis factor receptor levels are enhanced in infants with congenital heart disease

  2001cites this paper